Vanguard Global Advisers’s BioVie BIVI Stock Holding History

Vanguard Global Advisers’s Portfolio BIVI Stock Details BIVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-57	Closed	-$80	–	3652
2026 Q1	$80	Buy	+57	New	+$73	﹤0.01%	3678

Other funds holding BIVI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PTC

Philadelphia Trust Company Philadelphia, Pennsylvania $1.56B AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.37B AUM 71.69% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Global Advisers's BIVI Position: Q2 2026 in Review

Vanguard Global Advisers sold out of BioVie (BIVI) in Q2 2026, closing a stake of 57 shares — an estimated $80 sold.

Vanguard Global Advisers first reported a position in BIVI in Q1 2026 and held it in 1 quarter. The position peaked at $80 in Q1 2026. 34 funds tracked by Wall St. Rank hold BIVI as of Q2 2026.

Vanguard Global Advisers reported no remaining BioVie position as of Q2 2026 after selling out during the quarter.
Vanguard Global Advisers sold 57 BioVie shares in Q2 2026, an estimated $80.
Vanguard Global Advisers first reported a position in BioVie in Q1 2026 and held it in 1 quarter.
Vanguard Global Advisers's BioVie position peaked at $80 in Q1 2026.
34 funds tracked by Wall St. Rank held BioVie as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.